Vanguard Group’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.86M | Buy |
1,884,673
+50,045
| +3% | +$235K | ﹤0.01% | 2966 |
|
|
2025
Q1 | $6.7M | Buy |
1,834,628
+84,968
| +5% | +$310K | ﹤0.01% | 3060 |
|
|
2024
Q4 | $8.26M | Buy |
1,749,660
+17,681
| +1% | +$83.5K | ﹤0.01% | 3055 |
|
|
2024
Q3 | $16.1M | Buy |
1,731,979
+672,494
| +63% | +$6.26M | ﹤0.01% | 2706 |
|
|
2024
Q2 | $6.09M | Sell |
1,059,485
-43,008
| -4% | -$247K | ﹤0.01% | 3166 |
|
|
2024
Q1 | $7.4M | Buy |
1,102,493
+77,380
| +8% | +$519K | ﹤0.01% | 3126 |
|
|
2023
Q4 | $6.61M | Buy |
1,025,113
+6,434
| +0.6% | +$41.5K | ﹤0.01% | 3175 |
|
|
2023
Q3 | $5.09M | Buy |
1,018,679
+3,742
| +0.4% | +$18.7K | ﹤0.01% | 3240 |
|
|
2023
Q2 | $7.15M | Sell |
1,014,937
-7,028
| -0.7% | -$49.5K | ﹤0.01% | 3135 |
|
|
2023
Q1 | $6.34M | Buy |
1,021,965
+4,077
| +0.4% | +$25.3K | ﹤0.01% | 3195 |
|
|
2022
Q4 | $6.49M | Buy |
1,017,888
+4,966
| +0.5% | +$31.7K | ﹤0.01% | 3168 |
|
|
2022
Q3 | $8.69M | Buy |
1,012,922
+5,333
| +0.5% | +$45.8K | ﹤0.01% | 3018 |
|
|
2022
Q2 | $13.7M | Buy |
1,007,589
+146,819
| +17% | +$2M | ﹤0.01% | 2824 |
|
|
2022
Q1 | $13.1M | Buy |
860,770
+16,079
| +2% | +$245K | ﹤0.01% | 3008 |
|
|
2021
Q4 | $19.3M | Buy |
844,691
+4,774
| +0.6% | +$109K | ﹤0.01% | 2858 |
|
|
2021
Q3 | $11.7M | Buy |
839,917
+156,139
| +23% | +$2.17M | ﹤0.01% | 3149 |
|
|
2021
Q2 | $7.3M | Buy |
683,778
+276,444
| +68% | +$2.95M | ﹤0.01% | 3376 |
|
|
2021
Q1 | $5.37M | Buy |
407,334
+3,883
| +1% | +$51.2K | ﹤0.01% | 3495 |
|
|
2020
Q4 | $8.18M | Buy |
+403,451
| New | +$8.18M | ﹤0.01% | 3097 |
|